Novel motif:10: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ |
Latest revision as of 14:32, 9 September 2013
name: | motif10_SCGGAGASN |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0043503 | skeletal muscle fiber adaptation | 8.076358e-16 |
GO:0010624 | regulation of Schwann cell proliferation | 2.791473e-9 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 4.153981e-8 |
GO:0010625 | positive regulation of Schwann cell proliferation | 8.726935e-8 |
GO:0001957 | intramembranous ossification | 6.017916e-7 |
GO:0032863 | activation of Rac GTPase activity | 1.523769e-6 |
GO:0050703 | interleukin-1 alpha secretion | 1.813652e-6 |
GO:0043584 | nose development | 1.828313e-6 |
GO:0014028 | notochord formation | 1.910808e-6 |
GO:0007296 | vitellogenesis | 2.375393e-6 |
GO:0014037 | Schwann cell differentiation | 3.360609e-6 |
GO:0042133 | neurotransmitter metabolic process | 3.609882e-6 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 4.593906e-6 |
GO:0003229 | ventricular cardiac muscle tissue development | 5.276503e-6 |
GO:0046902 | regulation of mitochondrial membrane permeability | 5.383445e-6 |
GO:0006481 | C-terminal protein methylation | 5.450517e-6 |
GO:0014829 | vascular smooth muscle contraction | 6.013689e-6 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 7.271540e-6 |
GO:0060689 | cell differentiation involved in salivary gland development | 9.309841e-6 |
GO:0072298 | regulation of metanephric glomerulus development | 1.011159e-5 |
GO:0015864 | pyrimidine nucleoside transport | 1.134919e-5 |
GO:0002089 | lens morphogenesis in camera-type eye | 1.174007e-5 |
GO:0071044 | histone mRNA catabolic process | 1.235963e-5 |
GO:0032780 | negative regulation of ATPase activity | 1.302722e-5 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 1.805060e-5 |
GO:0001946 | lymphangiogenesis | 2.726445e-5 |
GO:0090150 | establishment of protein localization in membrane | 2.765030e-5 |
GO:0048075 | positive regulation of eye pigmentation | 2.848704e-5 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 2.981406e-5 |
GO:0045472 | response to ether | 3.423752e-5 |
GO:0010835 | regulation of protein ADP-ribosylation | 3.515580e-5 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 4.265446e-5 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 5.421704e-5 |
GO:0002380 | immunoglobulin secretion involved in immune response | 5.421704e-5 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 5.529211e-5 |
GO:0016557 | peroxisome membrane biogenesis | 5.808500e-5 |
GO:0043462 | regulation of ATPase activity | 6.136890e-5 |
GO:0018293 | protein-FAD linkage | 6.484996e-5 |
GO:0006423 | cysteinyl-tRNA aminoacylation | 6.484996e-5 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 6.484996e-5 |
GO:0071280 | cellular response to copper ion | 6.612218e-5 |
GO:0035470 | positive regulation of vascular wound healing | 6.937459e-5 |
GO:0070858 | negative regulation of bile acid biosynthetic process | 6.937459e-5 |
GO:0061102 | stomach neuroendocrine cell differentiation | 6.944725e-5 |
GO:0060165 | regulation of timing of subpallium neuron differentiation | 6.944725e-5 |
GO:0061104 | adrenal chromaffin cell differentiation | 6.944725e-5 |
GO:0071259 | cellular response to magnetism | 6.944725e-5 |
GO:0061103 | carotid body glomus cell differentiation | 6.944725e-5 |
GO:0061100 | lung neuroendocrine cell differentiation | 6.944725e-5 |
GO:0060163 | subpallium neuron fate commitment | 6.944725e-5 |
GO:0007400 | neuroblast fate determination | 6.944725e-5 |
GO:0003359 | noradrenergic neuron fate commitment | 6.944725e-5 |
GO:0048073 | regulation of eye pigmentation | 6.944725e-5 |
GO:0060035 | notochord cell development | 6.944725e-5 |
GO:0090281 | negative regulation of calcium ion import | 7.136462e-5 |
GO:0071584 | negative regulation of zinc ion import | 7.136462e-5 |
GO:0032506 | cytokinetic process | 8.548222e-5 |
GO:0021526 | medial motor column neuron differentiation | 9.466371e-5 |
GO:0009450 | gamma-aminobutyric acid catabolic process | 9.466371e-5 |
GO:0060670 | branching involved in embryonic placenta morphogenesis | 9.798271e-5 |
GO:0044342 | type B pancreatic cell proliferation | 1.027415e-4 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 1.027415e-4 |
GO:0006398 | histone mRNA 3'-end processing | 1.045553e-4 |
GO:0051764 | actin crosslink formation | 1.056101e-4 |
GO:0046952 | ketone body catabolic process | 1.120211e-4 |
GO:0060976 | coronary vasculature development | 1.176277e-4 |
GO:0006684 | sphingomyelin metabolic process | 1.184361e-4 |
GO:0060251 | regulation of glial cell proliferation | 1.194145e-4 |
GO:0070309 | lens fiber cell morphogenesis | 1.200176e-4 |
GO:0072300 | positive regulation of metanephric glomerulus development | 1.313472e-4 |
GO:0019048 | virus-host interaction | 1.435871e-4 |
GO:0097045 | phosphatidylserine exposure on blood platelet | 1.487514e-4 |
GO:0051645 | Golgi localization | 1.516527e-4 |
GO:0072661 | protein targeting to plasma membrane | 1.737188e-4 |
GO:0042137 | sequestering of neurotransmitter | 1.737188e-4 |
GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 1.882781e-4 |
GO:0048486 | parasympathetic nervous system development | 2.039195e-4 |
GO:0003009 | skeletal muscle contraction | 2.206202e-4 |
GO:0045007 | depurination | 2.207443e-4 |
GO:0015842 | synaptic vesicle amine transport | 2.207443e-4 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 2.336512e-4 |
GO:0090002 | establishment of protein localization in plasma membrane | 2.365088e-4 |
GO:0060923 | cardiac muscle cell fate commitment | 2.414081e-4 |
GO:0021523 | somatic motor neuron differentiation | 2.425284e-4 |
GO:0007522 | visceral muscle development | 2.435469e-4 |
GO:0051298 | centrosome duplication | 2.460633e-4 |
GO:0050891 | multicellular organismal water homeostasis | 2.834423e-4 |
GO:0070682 | proteasome regulatory particle assembly | 2.836055e-4 |
GO:0034766 | negative regulation of ion transmembrane transport | 2.836055e-4 |
GO:0014044 | Schwann cell development | 2.882621e-4 |
GO:0015862 | uridine transport | 2.904051e-4 |
GO:0043501 | skeletal muscle adaptation | 2.916645e-4 |
GO:0070509 | calcium ion import | 2.972342e-4 |
GO:0021528 | commissural neuron differentiation in spinal cord | 3.100536e-4 |
GO:0010836 | negative regulation of protein ADP-ribosylation | 3.100536e-4 |
GO:0042135 | neurotransmitter catabolic process | 3.117121e-4 |
GO:2000001 | regulation of DNA damage checkpoint | 3.131214e-4 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 3.188014e-4 |
GO:0060061 | Spemann organizer formation | 3.297189e-4 |
GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 3.297189e-4 |
GO:0021783 | preganglionic parasympathetic nervous system development | 3.305312e-4 |
GO:0006685 | sphingomyelin catabolic process | 3.425198e-4 |
GO:0071585 | detoxification of cadmium ion | 3.635431e-4 |
GO:0030488 | tRNA methylation | 3.635431e-4 |
GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions | 3.650608e-4 |
GO:0090361 | regulation of platelet-derived growth factor production | 3.660572e-4 |
GO:0061205 | paramesonephric duct development | 3.817292e-4 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 3.898022e-4 |
GO:0051546 | keratinocyte migration | 3.975888e-4 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 4.036418e-4 |
GO:0060712 | spongiotrophoblast layer development | 4.089192e-4 |
GO:0035566 | regulation of metanephros size | 4.116293e-4 |
GO:0010226 | response to lithium ion | 4.178606e-4 |
GO:0022011 | myelination in peripheral nervous system | 4.310074e-4 |
GO:0006356 | regulation of transcription from RNA polymerase I promoter | 4.465358e-4 |
GO:0018993 | somatic sex determination | 4.805773e-4 |
GO:0051561 | elevation of mitochondrial calcium ion concentration | 4.921042e-4 |
GO:0034505 | tooth mineralization | 5.176227e-4 |
GO:0008334 | histone mRNA metabolic process | 5.414998e-4 |
GO:0060020 | Bergmann glial cell differentiation | 5.441591e-4 |
GO:0019087 | transformation of host cell by virus | 5.442145e-4 |
GO:0051013 | microtubule severing | 5.555839e-4 |
GO:0032790 | ribosome disassembly | 5.555839e-4 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 5.756863e-4 |
GO:0001826 | inner cell mass cell differentiation | 5.994013e-4 |
GO:0043491 | protein kinase B signaling cascade | 6.156777e-4 |
GO:0045838 | positive regulation of membrane potential | 6.223751e-4 |
GO:0060580 | ventral spinal cord interneuron fate determination | 6.262702e-4 |
GO:0003327 | type B pancreatic cell fate commitment | 6.262702e-4 |
GO:0070625 | zymogen granule exocytosis | 6.462638e-4 |
GO:0035865 | cellular response to potassium ion | 6.462638e-4 |
GO:0032342 | aldosterone biosynthetic process | 6.462638e-4 |
GO:0034651 | cortisol biosynthetic process | 6.462638e-4 |
GO:0031427 | response to methotrexate | 6.696354e-4 |
GO:0032218 | riboflavin transport | 6.780932e-4 |
GO:0021586 | pons maturation | 6.780932e-4 |
GO:0042048 | olfactory behavior | 6.834579e-4 |
GO:0043585 | nose morphogenesis | 7.027440e-4 |
GO:0048320 | axial mesoderm formation | 7.196999e-4 |
GO:0007031 | peroxisome organization | 7.483963e-4 |
GO:0001661 | conditioned taste aversion | 7.745002e-4 |
GO:0060346 | bone trabecula formation | 7.892748e-4 |
GO:2000369 | regulation of clathrin-mediated endocytosis | 7.908483e-4 |
GO:0015809 | arginine transport | 8.370536e-4 |
GO:0006984 | ER-nucleus signaling pathway | 8.378954e-4 |
GO:0032211 | negative regulation of telomere maintenance via telomerase | 8.392415e-4 |
GO:0010626 | negative regulation of Schwann cell proliferation | 9.136716e-4 |
GO:0060539 | diaphragm development | 9.263263e-4 |
GO:0015816 | glycine transport | 9.637420e-4 |
GO:0043574 | peroxisomal transport | 9.653246e-4 |
GO:0048247 | lymphocyte chemotaxis | 1.030632e-3 |
GO:0072659 | protein localization in plasma membrane | 1.056473e-3 |
GO:0032074 | negative regulation of nuclease activity | 1.077393e-3 |
GO:0031119 | tRNA pseudouridine synthesis | 1.077393e-3 |
GO:0019428 | allantoin biosynthetic process | 1.077393e-3 |
GO:0015969 | guanosine tetraphosphate metabolic process | 1.077393e-3 |
GO:0060690 | epithelial cell differentiation involved in salivary gland development | 1.080894e-3 |
GO:0048549 | positive regulation of pinocytosis | 1.080894e-3 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.101671e-3 |
GO:0019054 | modulation by virus of host cellular process | 1.122758e-3 |
GO:0060669 | embryonic placenta morphogenesis | 1.127955e-3 |
GO:0060154 | cellular process regulating host cell cycle in response to virus | 1.137465e-3 |
GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin | 1.149295e-3 |
GO:0048246 | macrophage chemotaxis | 1.201027e-3 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 1.256600e-3 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 1.256600e-3 |
GO:0043973 | histone H3-K4 acetylation | 1.256600e-3 |
GO:0042335 | cuticle development | 1.268989e-3 |
GO:0007135 | meiosis II | 1.268989e-3 |
GO:0003097 | renal water transport | 1.314755e-3 |
GO:0006285 | base-excision repair, AP site formation | 1.314965e-3 |
GO:0030910 | olfactory placode formation | 1.334331e-3 |
GO:0030237 | female sex determination | 1.345854e-3 |
GO:0046168 | glycerol-3-phosphate catabolic process | 1.347039e-3 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 1.366907e-3 |
GO:0033057 | multicellular organismal reproductive behavior | 1.373691e-3 |
GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin | 1.400628e-3 |
GO:0007614 | short-term memory | 1.428336e-3 |
GO:0003407 | neural retina development | 1.522664e-3 |
GO:0060370 | susceptibility to T cell mediated cytotoxicity | 1.540503e-3 |
GO:0035814 | negative regulation of renal sodium excretion | 1.627996e-3 |
GO:0043415 | positive regulation of skeletal muscle tissue regeneration | 1.730317e-3 |
GO:0060430 | lung saccule development | 1.732305e-3 |
GO:0032862 | activation of Rho GTPase activity | 1.765063e-3 |
GO:0006540 | glutamate decarboxylation to succinate | 1.794525e-3 |
GO:0035491 | positive regulation of leukotriene production involved in inflammatory response | 1.833884e-3 |
GO:0071258 | cellular response to gravity | 1.833884e-3 |
GO:2000098 | negative regulation of smooth muscle cell-matrix adhesion | 1.833884e-3 |
GO:0061044 | negative regulation of vascular wound healing | 1.833884e-3 |
GO:0050881 | musculoskeletal movement | 1.865723e-3 |
GO:2000097 | regulation of smooth muscle cell-matrix adhesion | 1.882847e-3 |
GO:0043097 | pyrimidine nucleoside salvage | 2.036770e-3 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 2.084377e-3 |
GO:0000088 | mitotic prophase | 2.084377e-3 |
GO:0032417 | positive regulation of sodium:hydrogen antiporter activity | 2.102497e-3 |
GO:0007512 | adult heart development | 2.147726e-3 |
GO:0071218 | cellular response to misfolded protein | 2.215975e-3 |
GO:0060611 | mammary gland fat development | 2.217005e-3 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 2.217005e-3 |
GO:0042703 | menstruation | 2.223277e-3 |
GO:0019101 | female somatic sex determination | 2.223277e-3 |
GO:0003406 | retinal pigment epithelium development | 2.223277e-3 |
GO:0042117 | monocyte activation | 2.235124e-3 |
GO:0060929 | atrioventricular node cell fate commitment | 2.250844e-3 |
GO:0003168 | cardiac Purkinje fiber cell differentiation | 2.250844e-3 |
GO:0060928 | atrioventricular node cell development | 2.250844e-3 |
GO:0016140 | O-glycoside metabolic process | 2.250844e-3 |
GO:0003342 | proepicardium development | 2.250844e-3 |
GO:0033326 | cerebrospinal fluid secretion | 2.317496e-3 |
GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process | 2.317496e-3 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 2.336843e-3 |
GO:0060014 | granulosa cell differentiation | 2.378205e-3 |
GO:0014002 | astrocyte development | 2.443734e-3 |
GO:0002309 | T cell proliferation involved in immune response | 2.516718e-3 |
GO:0070857 | regulation of bile acid biosynthetic process | 2.679495e-3 |
GO:0035105 | sterol regulatory element binding protein import into nucleus | 2.679495e-3 |
GO:0021603 | cranial nerve formation | 2.682071e-3 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 2.706658e-3 |
GO:0009440 | cyanate catabolic process | 2.745571e-3 |
GO:0030953 | astral microtubule organization | 2.767250e-3 |
GO:0006287 | base-excision repair, gap-filling | 2.772199e-3 |
GO:0071423 | malate transmembrane transport | 2.807684e-3 |
GO:0015709 | thiosulfate transport | 2.807684e-3 |
GO:0048241 | epinephrine transport | 2.931381e-3 |
GO:0003285 | septum secundum development | 2.931381e-3 |
GO:0060253 | negative regulation of glial cell proliferation | 2.969151e-3 |
GO:0033002 | muscle cell proliferation | 2.969151e-3 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 2.978970e-3 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 3.006585e-3 |
GO:0060971 | embryonic heart tube left/right pattern formation | 3.009426e-3 |
GO:0060920 | pacemaker cell differentiation | 3.009426e-3 |
GO:0022027 | interkinetic nuclear migration | 3.061331e-3 |
GO:0016558 | protein import into peroxisome matrix | 3.061331e-3 |
GO:0030916 | otic vesicle formation | 3.118169e-3 |
GO:0031122 | cytoplasmic microtubule organization | 3.171295e-3 |
GO:0043508 | negative regulation of JUN kinase activity | 3.222103e-3 |
GO:0006625 | protein targeting to peroxisome | 3.241620e-3 |
GO:0002074 | extraocular skeletal muscle development | 3.372192e-3 |
GO:0006083 | acetate metabolic process | 3.375082e-3 |
GO:0000920 | cytokinetic cell separation | 3.406908e-3 |
GO:0002268 | follicular dendritic cell differentiation | 3.483639e-3 |
GO:0008355 | olfactory learning | 3.506497e-3 |
GO:0061143 | alveolar primary septum development | 3.506497e-3 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 3.655902e-3 |
GO:0014909 | smooth muscle cell migration | 3.675296e-3 |
GO:0060662 | salivary gland cavitation | 3.731072e-3 |
GO:0002071 | glandular epithelial cell maturation | 3.956298e-3 |
GO:0000917 | barrier septum formation | 3.956298e-3 |
GO:0051488 | activation of anaphase-promoting complex activity | 4.089533e-3 |
GO:0051580 | regulation of neurotransmitter uptake | 4.109458e-3 |
GO:0030421 | defecation | 4.121517e-3 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 4.138289e-3 |
GO:0046015 | regulation of transcription by glucose | 4.144427e-3 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 4.147316e-3 |
GO:0042149 | cellular response to glucose starvation | 4.165966e-3 |
GO:0060977 | coronary vasculature morphogenesis | 4.217459e-3 |
GO:0021612 | facial nerve structural organization | 4.217459e-3 |
GO:0035499 | carnosine biosynthetic process | 4.217649e-3 |
GO:0009386 | translational attenuation | 4.217649e-3 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 4.217649e-3 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 4.226030e-3 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 4.274747e-3 |
GO:0033561 | regulation of water loss via skin | 4.315656e-3 |
GO:0015747 | urate transport | 4.315656e-3 |
GO:0015858 | nucleoside transport | 4.345969e-3 |
GO:0017121 | phospholipid scrambling | 4.586216e-3 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 4.758707e-3 |
GO:0008535 | respiratory chain complex IV assembly | 4.758707e-3 |
GO:0060133 | somatotropin secreting cell development | 4.983368e-3 |
GO:0044088 | regulation of vacuole organization | 4.983368e-3 |
GO:0046174 | polyol catabolic process | 4.983368e-3 |
GO:0051299 | centrosome separation | 5.083066e-3 |
GO:0021569 | rhombomere 3 development | 5.137470e-3 |
GO:0048570 | notochord morphogenesis | 5.137470e-3 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 5.158362e-3 |
GO:0048168 | regulation of neuronal synaptic plasticity | 5.323036e-3 |
GO:0045046 | protein import into peroxisome membrane | 5.338914e-3 |
GO:2000744 | positive regulation of anterior head development | 5.340108e-3 |
GO:0015742 | alpha-ketoglutarate transport | 5.340108e-3 |
GO:0003310 | pancreatic A cell differentiation | 5.413563e-3 |
GO:0060419 | heart growth | 5.462495e-3 |
GO:0033133 | positive regulation of glucokinase activity | 5.478660e-3 |
GO:0072162 | metanephric mesenchymal cell differentiation | 5.523563e-3 |
GO:0035967 | cellular response to topologically incorrect protein | 5.733840e-3 |
GO:0045925 | positive regulation of female receptivity | 5.852126e-3 |
GO:0060450 | positive regulation of hindgut contraction | 5.852126e-3 |
GO:0042747 | circadian sleep/wake cycle, REM sleep | 5.852126e-3 |
GO:0042418 | epinephrine biosynthetic process | 5.852126e-3 |
GO:0006585 | dopamine biosynthetic process from tyrosine | 5.852126e-3 |
GO:0019358 | nicotinate nucleotide salvage | 5.852126e-3 |
GO:0014908 | myotube differentiation involved in skeletal muscle regeneration | 5.852126e-3 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 5.852126e-3 |
GO:0090193 | positive regulation of glomerulus development | 5.872559e-3 |
GO:0043049 | otic placode formation | 5.915888e-3 |
GO:0010045 | response to nickel ion | 5.932801e-3 |
GO:0061101 | neuroendocrine cell differentiation | 5.971362e-3 |
GO:0006220 | pyrimidine nucleotide metabolic process | 6.051955e-3 |
GO:0055017 | cardiac muscle tissue growth | 6.362607e-3 |
GO:0060042 | retina morphogenesis in camera-type eye | 6.393643e-3 |
GO:2000143 | negative regulation of transcription initiation, DNA-dependent | 6.435323e-3 |
GO:0042471 | ear morphogenesis | 6.471616e-3 |
GO:0060455 | negative regulation of gastric acid secretion | 6.639656e-3 |
GO:0006391 | transcription initiation from mitochondrial promoter | 6.639656e-3 |
GO:0048050 | post-embryonic eye morphogenesis | 6.639656e-3 |
GO:0060038 | cardiac muscle cell proliferation | 6.706047e-3 |
GO:0048242 | epinephrine secretion | 6.715620e-3 |
GO:0046108 | uridine metabolic process | 6.715620e-3 |
GO:0043615 | astrocyte cell migration | 6.717730e-3 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 6.734346e-3 |
GO:0042220 | response to cocaine | 6.848889e-3 |
GO:0021666 | rhombomere 5 formation | 6.883755e-3 |
GO:0002551 | mast cell chemotaxis | 6.883755e-3 |
GO:0021660 | rhombomere 3 formation | 6.883755e-3 |
GO:0045906 | negative regulation of vasoconstriction | 6.890484e-3 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 7.038381e-3 |
GO:0060708 | spongiotrophoblast differentiation | 7.214208e-3 |
GO:0090344 | negative regulation of cell aging | 7.254084e-3 |
GO:0072668 | tubulin complex biogenesis | 7.445015e-3 |
GO:0060126 | somatotropin secreting cell differentiation | 7.543687e-3 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 7.589019e-3 |
GO:0035732 | nitric oxide storage | 7.622790e-3 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 7.622790e-3 |
GO:0042407 | cristae formation | 7.622790e-3 |
GO:0035726 | common myeloid progenitor cell proliferation | 7.622790e-3 |
GO:0019088 | immortalization of host cell by virus | 7.622790e-3 |
GO:0006231 | dTMP biosynthetic process | 7.622790e-3 |
GO:0022004 | midbrain-hindbrain boundary maturation during brain development | 7.654021e-3 |
GO:2000002 | negative regulation of DNA damage checkpoint | 7.654021e-3 |
GO:0021588 | cerebellum formation | 7.654021e-3 |
GO:0021551 | central nervous system morphogenesis | 7.654021e-3 |
GO:0050775 | positive regulation of dendrite morphogenesis | 7.750644e-3 |
GO:0008033 | tRNA processing | 7.775596e-3 |
GO:0009952 | anterior/posterior pattern specification | 8.066286e-3 |
GO:0003091 | renal water homeostasis | 8.067153e-3 |
GO:0006449 | regulation of translational termination | 8.120901e-3 |
GO:0060179 | male mating behavior | 8.153642e-3 |
GO:0016255 | attachment of GPI anchor to protein | 8.154182e-3 |
GO:0045657 | positive regulation of monocyte differentiation | 8.154182e-3 |
GO:0046588 | negative regulation of calcium-dependent cell-cell adhesion | 8.162692e-3 |
GO:0032108 | negative regulation of response to nutrient levels | 8.184653e-3 |
GO:0050685 | positive regulation of mRNA processing | 8.241263e-3 |
GO:0021561 | facial nerve development | 8.366901e-3 |
GO:0009448 | gamma-aminobutyric acid metabolic process | 8.387042e-3 |
GO:0061360 | optic chiasma development | 8.436158e-3 |
GO:0035799 | ureter maturation | 8.436158e-3 |
GO:2000597 | positive regulation of optic nerve formation | 8.436158e-3 |
GO:0021633 | optic nerve structural organization | 8.436158e-3 |
GO:0021650 | vestibulocochlear nerve formation | 8.436158e-3 |
GO:0021542 | dentate gyrus development | 8.727659e-3 |
GO:0072268 | pattern specification involved in metanephros development | 8.789960e-3 |
GO:0051835 | positive regulation of synapse structural plasticity | 8.859332e-3 |
GO:0042488 | positive regulation of odontogenesis of dentine-containing tooth | 8.859332e-3 |
GO:0009151 | purine deoxyribonucleotide metabolic process | 9.168721e-3 |
GO:0002027 | regulation of heart rate | 9.343641e-3 |
GO:0006268 | DNA unwinding involved in replication | 9.376292e-3 |
GO:0060123 | regulation of growth hormone secretion | 9.386936e-3 |
GO:0051891 | positive regulation of cardioblast differentiation | 9.475017e-3 |
GO:0007422 | peripheral nervous system development | 9.572281e-3 |
GO:0060252 | positive regulation of glial cell proliferation | 9.731135e-3 |
GO:0000414 | regulation of histone H3-K36 methylation | 9.874086e-3 |
GO:2000786 | positive regulation of autophagic vacuole assembly | 9.925388e-3 |
GO:0042766 | nucleosome mobilization | 9.925388e-3 |
GO:0070537 | histone H2A K63-linked deubiquitination | 9.925388e-3 |
GO:0014888 | striated muscle adaptation | 9.953086e-3 |
GO:0044068 | modulation by symbiont of host cellular process | 1.023740e-2 |
GO:0002575 | basophil chemotaxis | 1.026903e-2 |
GO:0060319 | primitive erythrocyte differentiation | 1.026903e-2 |
GO:0060337 | type I interferon-mediated signaling pathway | 1.028406e-2 |
GO:0007130 | synaptonemal complex assembly | 1.029010e-2 |
GO:0003222 | ventricular trabecular myocardium morphogenesis | 1.033808e-2 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 1.033808e-2 |
GO:0042711 | maternal behavior | 1.047123e-2 |
GO:0018410 | C-terminal protein amino acid modification | 1.086563e-2 |
GO:0071316 | cellular response to nicotine | 1.106669e-2 |
GO:0043586 | tongue development | 1.111514e-2 |
GO:0006400 | tRNA modification | 1.112148e-2 |
GO:0021658 | rhombomere 3 morphogenesis | 1.121638e-2 |
GO:0015870 | acetylcholine transport | 1.121638e-2 |
GO:0048548 | regulation of pinocytosis | 1.129430e-2 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 1.129430e-2 |
GO:0043084 | penile erection | 1.130675e-2 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 1.163958e-2 |
GO:0048167 | regulation of synaptic plasticity | 1.168141e-2 |
GO:0033629 | negative regulation of cell adhesion mediated by integrin | 1.170271e-2 |
GO:0032717 | negative regulation of interleukin-8 production | 1.170271e-2 |
GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 1.184148e-2 |
GO:0097107 | postsynaptic density assembly | 1.184148e-2 |
GO:0019682 | glyceraldehyde-3-phosphate metabolic process | 1.184148e-2 |
GO:0043000 | Golgi to plasma membrane CFTR protein transport | 1.184148e-2 |
GO:0071104 | response to interleukin-9 | 1.184148e-2 |
GO:0015670 | carbon dioxide transport | 1.195401e-2 |
GO:0006284 | base-excision repair | 1.214629e-2 |
GO:0060371 | regulation of atrial cardiomyocyte membrane depolarization | 1.219766e-2 |
GO:0071469 | cellular response to alkalinity | 1.219766e-2 |
GO:0044140 | negative regulation of growth of symbiont on or near host surface | 1.219766e-2 |
GO:2000009 | negative regulation of protein localization at cell surface | 1.219766e-2 |
GO:0031860 | telomeric 3' overhang formation | 1.219766e-2 |
GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation | 1.219766e-2 |
GO:0015761 | mannose transport | 1.219766e-2 |
GO:0030865 | cortical cytoskeleton organization | 1.225851e-2 |
GO:0090005 | negative regulation of establishment of protein localization in plasma membrane | 1.235611e-2 |
GO:0072329 | monocarboxylic acid catabolic process | 1.237941e-2 |
GO:0045655 | regulation of monocyte differentiation | 1.240027e-2 |
GO:0009062 | fatty acid catabolic process | 1.240970e-2 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 1.272062e-2 |
GO:0060040 | retinal bipolar neuron differentiation | 1.285506e-2 |
GO:0060763 | mammary duct terminal end bud growth | 1.286490e-2 |
GO:0048593 | camera-type eye morphogenesis | 1.290045e-2 |
GO:2000077 | negative regulation of type B pancreatic cell development | 1.311487e-2 |
GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter | 1.321171e-2 |
GO:0003360 | brainstem development | 1.321171e-2 |
GO:0000244 | assembly of spliceosomal tri-snRNP | 1.344942e-2 |
GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter | 1.348199e-2 |
GO:0030866 | cortical actin cytoskeleton organization | 1.360142e-2 |
GO:0052314 | phytoalexin metabolic process | 1.362831e-2 |
GO:0072553 | terminal button organization | 1.362831e-2 |
GO:0033342 | negative regulation of collagen binding | 1.362831e-2 |
GO:0009163 | nucleoside biosynthetic process | 1.363041e-2 |
GO:0007099 | centriole replication | 1.372339e-2 |
GO:0090192 | regulation of glomerulus development | 1.373729e-2 |
GO:0003329 | pancreatic PP cell fate commitment | 1.388076e-2 |
GO:0003326 | pancreatic A cell fate commitment | 1.388076e-2 |
GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 1.406780e-2 |
GO:0043012 | regulation of fusion of sperm to egg plasma membrane | 1.449284e-2 |
GO:0042414 | epinephrine metabolic process | 1.449284e-2 |
GO:0097151 | positive regulation of inhibitory postsynaptic membrane potential | 1.449284e-2 |
GO:0002033 | vasodilation by angiotensin involved in regulation of systemic arterial blood pressure | 1.449284e-2 |
GO:0032581 | ER-dependent peroxisome organization | 1.449284e-2 |
GO:0007136 | meiotic prophase II | 1.449284e-2 |
GO:0030047 | actin modification | 1.449284e-2 |
GO:0061013 | regulation of mRNA catabolic process | 1.514658e-2 |
GO:0042136 | neurotransmitter biosynthetic process | 1.514658e-2 |
GO:0090140 | regulation of mitochondrial fission | 1.518809e-2 |
GO:0060343 | trabecula formation | 1.540895e-2 |
GO:0045948 | positive regulation of translational initiation | 1.542983e-2 |
GO:0060166 | olfactory pit development | 1.545785e-2 |
GO:0061383 | trabecula morphogenesis | 1.553604e-2 |
GO:0072075 | metanephric mesenchyme development | 1.560144e-2 |
GO:0042472 | inner ear morphogenesis | 1.574301e-2 |
GO:0032210 | regulation of telomere maintenance via telomerase | 1.607372e-2 |
GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine | 1.618892e-2 |
GO:0007182 | common-partner SMAD protein phosphorylation | 1.618892e-2 |
GO:0034340 | response to type I interferon | 1.629259e-2 |
GO:0045994 | positive regulation of translational initiation by iron | 1.632082e-2 |
GO:0006701 | progesterone biosynthetic process | 1.632082e-2 |
GO:0002037 | negative regulation of L-glutamate transport | 1.632082e-2 |
GO:0007195 | inhibition of adenylate cyclase activity by dopamine receptor signaling pathway | 1.637835e-2 |
GO:0033299 | secretion of lysosomal enzymes | 1.640094e-2 |
GO:0018352 | protein-pyridoxal-5-phosphate linkage | 1.640094e-2 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 1.640094e-2 |
GO:0034976 | response to endoplasmic reticulum stress | 1.648526e-2 |
GO:0045908 | negative regulation of vasodilation | 1.664089e-2 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 1.664089e-2 |
GO:2000114 | regulation of establishment of cell polarity | 1.695409e-2 |
GO:0006289 | nucleotide-excision repair | 1.707983e-2 |
GO:0070193 | synaptonemal complex organization | 1.732521e-2 |
GO:0021610 | facial nerve morphogenesis | 1.732680e-2 |
GO:0090026 | positive regulation of monocyte chemotaxis | 1.733398e-2 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 1.736944e-2 |
GO:0046501 | protoporphyrinogen IX metabolic process | 1.769347e-2 |
GO:0044154 | histone H3-K14 acetylation | 1.780515e-2 |
GO:0007009 | plasma membrane organization | 1.805054e-2 |
GO:0070314 | G1 to G0 transition | 1.847110e-2 |
GO:0050965 | detection of temperature stimulus involved in sensory perception of pain | 1.847110e-2 |
GO:0010735 | positive regulation of transcription via serum response element binding | 1.847110e-2 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 1.876030e-2 |
GO:0071421 | manganese ion transmembrane transport | 1.887738e-2 |
GO:0061054 | dermatome development | 1.932606e-2 |
GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 1.964632e-2 |
GO:0001300 | chronological cell aging | 2.006084e-2 |
GO:0060385 | axonogenesis involved in innervation | 2.010831e-2 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 2.010831e-2 |
GO:0031999 | negative regulation of fatty acid beta-oxidation | 2.013639e-2 |
GO:0060235 | lens induction in camera-type eye | 2.022957e-2 |
GO:0007621 | negative regulation of female receptivity | 2.037367e-2 |
GO:0072277 | metanephric glomerular capillary formation | 2.039909e-2 |
GO:0070192 | chromosome organization involved in meiosis | 2.081119e-2 |
GO:0048172 | regulation of short-term neuronal synaptic plasticity | 2.091628e-2 |
GO:0014707 | branchiomeric skeletal muscle development | 2.094961e-2 |
GO:0061017 | hepatoblast differentiation | 2.105551e-2 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 2.105551e-2 |
GO:0071733 | transcriptional activation by promoter-enhancer looping | 2.110463e-2 |
GO:0097152 | mesenchymal cell apoptosis | 2.110463e-2 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 2.110463e-2 |
GO:0060982 | coronary artery morphogenesis | 2.110463e-2 |
GO:0019405 | alditol catabolic process | 2.110463e-2 |
GO:0048561 | establishment of organ orientation | 2.110463e-2 |
GO:0010724 | regulation of definitive erythrocyte differentiation | 2.110463e-2 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 2.110463e-2 |
GO:0002679 | respiratory burst involved in defense response | 2.136539e-2 |
GO:0048563 | post-embryonic organ morphogenesis | 2.138501e-2 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 2.139739e-2 |
GO:0006635 | fatty acid beta-oxidation | 2.165450e-2 |
GO:0030903 | notochord development | 2.202974e-2 |
GO:0032096 | negative regulation of response to food | 2.203524e-2 |
GO:0006474 | N-terminal protein amino acid acetylation | 2.217613e-2 |
GO:0070574 | cadmium ion transmembrane transport | 2.240947e-2 |
GO:0046950 | cellular ketone body metabolic process | 2.240947e-2 |
GO:0072086 | specification of loop of Henle identity | 2.255905e-2 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 2.256239e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0006188 | IMP biosynthetic process | 4.771503e-7 |
GO:0046039 | GTP metabolic process | 1.565582e-6 |
GO:0006184 | GTP catabolic process | 5.655844e-6 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 9.258396e-6 |
GO:0009113 | purine base biosynthetic process | 9.258396e-6 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 1.519421e-5 |
GO:0071173 | spindle assembly checkpoint | 1.736046e-5 |
GO:0032717 | negative regulation of interleukin-8 production | 2.410573e-5 |
GO:0051925 | regulation of calcium ion transport via voltage-gated calcium channel activity | 4.136887e-5 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 4.264651e-5 |
GO:0035249 | synaptic transmission, glutamatergic | 5.347352e-5 |
GO:0009134 | nucleoside diphosphate catabolic process | 5.973642e-5 |
GO:0060033 | anatomical structure regression | 6.449762e-5 |
GO:0002031 | G-protein coupled receptor internalization | 6.507647e-5 |
GO:0030520 | estrogen receptor signaling pathway | 6.952388e-5 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 6.967745e-5 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 7.682825e-5 |
GO:0043973 | histone H3-K4 acetylation | 7.794462e-5 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 7.794462e-5 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 7.794462e-5 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 8.098756e-5 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 9.604616e-5 |
GO:0051901 | positive regulation of mitochondrial depolarization | 1.003604e-4 |
GO:0032481 | positive regulation of type I interferon production | 1.049780e-4 |
GO:0006189 | 'de novo' IMP biosynthetic process | 1.094822e-4 |
GO:0071480 | cellular response to gamma radiation | 1.203922e-4 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 1.492800e-4 |
GO:0010984 | regulation of lipoprotein particle clearance | 1.550538e-4 |
GO:0050916 | sensory perception of sweet taste | 1.558733e-4 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 1.658807e-4 |
GO:0045351 | type I interferon biosynthetic process | 1.667805e-4 |
GO:0046092 | deoxycytidine metabolic process | 2.056968e-4 |
GO:0016557 | peroxisome membrane biogenesis | 2.056968e-4 |
GO:0032365 | intracellular lipid transport | 2.099482e-4 |
GO:0007254 | JNK cascade | 2.345908e-4 |
GO:0001945 | lymph vessel development | 2.378779e-4 |
GO:0031577 | spindle checkpoint | 2.617863e-4 |
GO:0000305 | response to oxygen radical | 2.718888e-4 |
GO:0009261 | ribonucleotide catabolic process | 2.775752e-4 |
GO:0010625 | positive regulation of Schwann cell proliferation | 2.985538e-4 |
GO:0031098 | stress-activated protein kinase signaling cascade | 3.005707e-4 |
GO:0046655 | folic acid metabolic process | 3.139383e-4 |
GO:0046785 | microtubule polymerization | 3.170313e-4 |
GO:0043314 | negative regulation of neutrophil degranulation | 3.540588e-4 |
GO:0010633 | negative regulation of epithelial cell migration | 3.773842e-4 |
GO:0045080 | positive regulation of chemokine biosynthetic process | 3.783505e-4 |
GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway | 4.159020e-4 |
GO:0045925 | positive regulation of female receptivity | 4.184019e-4 |
GO:0048268 | clathrin coat assembly | 4.196511e-4 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 4.261783e-4 |
GO:0032479 | regulation of type I interferon production | 4.383990e-4 |
GO:0009154 | purine ribonucleotide catabolic process | 4.528789e-4 |
GO:0009150 | purine ribonucleotide metabolic process | 4.612492e-4 |
GO:0033120 | positive regulation of RNA splicing | 4.751642e-4 |
GO:0008595 | anterior/posterior axis specification, embryo | 4.999647e-4 |
GO:0055099 | response to high density lipoprotein particle stimulus | 5.191447e-4 |
GO:0010833 | telomere maintenance via telomere lengthening | 5.191447e-4 |
GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 5.320218e-4 |
GO:0007354 | zygotic determination of anterior/posterior axis, embryo | 5.332222e-4 |
GO:0051029 | rRNA transport | 5.332222e-4 |
GO:0048340 | paraxial mesoderm morphogenesis | 5.634704e-4 |
GO:0046709 | IDP catabolic process | 5.957541e-4 |
GO:0046032 | ADP catabolic process | 5.957541e-4 |
GO:0006901 | vesicle coating | 6.366510e-4 |
GO:0050951 | sensory perception of temperature stimulus | 6.669727e-4 |
GO:0003273 | cell migration involved in endocardial cushion formation | 6.719701e-4 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 7.143411e-4 |
GO:0045046 | protein import into peroxisome membrane | 7.264618e-4 |
GO:0043301 | negative regulation of leukocyte degranulation | 7.463646e-4 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 7.509130e-4 |
GO:0007356 | thorax and anterior abdomen determination | 7.509130e-4 |
GO:2001076 | positive regulation of metanephric ureteric bud development | 7.509130e-4 |
GO:0002536 | respiratory burst involved in inflammatory response | 7.509130e-4 |
GO:0002155 | regulation of thyroid hormone mediated signaling pathway | 7.509130e-4 |
GO:0032855 | positive regulation of Rac GTPase activity | 7.613160e-4 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 7.940438e-4 |
GO:0048341 | paraxial mesoderm formation | 7.955592e-4 |
GO:0050995 | negative regulation of lipid catabolic process | 8.363007e-4 |
GO:0033344 | cholesterol efflux | 8.454109e-4 |
GO:0046037 | GMP metabolic process | 9.360642e-4 |
GO:0050917 | sensory perception of umami taste | 9.924017e-4 |
GO:0060708 | spongiotrophoblast differentiation | 9.924017e-4 |
GO:0010536 | positive regulation of activation of Janus kinase activity | 9.924017e-4 |
GO:0043506 | regulation of JUN kinase activity | 1.001565e-3 |
GO:0051026 | chiasma assembly | 1.015459e-3 |
GO:0035176 | social behavior | 1.102496e-3 |
GO:0008616 | queuosine biosynthetic process | 1.125492e-3 |
GO:0046373 | L-arabinose metabolic process | 1.125492e-3 |
GO:0090234 | regulation of kinetochore assembly | 1.133831e-3 |
GO:0090169 | regulation of spindle assembly | 1.133831e-3 |
GO:0050965 | detection of temperature stimulus involved in sensory perception of pain | 1.242559e-3 |
GO:0070389 | chaperone cofactor-dependent protein refolding | 1.266539e-3 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 1.284165e-3 |
GO:0060923 | cardiac muscle cell fate commitment | 1.314947e-3 |
GO:0070483 | detection of hypoxia | 1.337755e-3 |
GO:0060457 | negative regulation of digestive system process | 1.337755e-3 |
GO:0016601 | Rac protein signal transduction | 1.340386e-3 |
GO:0071594 | thymocyte aggregation | 1.395189e-3 |
GO:0007196 | inhibition of adenylate cyclase activity by metabotropic glutamate receptor signaling pathway | 1.395189e-3 |
GO:0060319 | primitive erythrocyte differentiation | 1.466739e-3 |
GO:0009146 | purine nucleoside triphosphate catabolic process | 1.470795e-3 |
GO:0060710 | chorio-allantoic fusion | 1.481376e-3 |
GO:0055017 | cardiac muscle tissue growth | 1.481376e-3 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 1.485309e-3 |
GO:0000303 | response to superoxide | 1.522950e-3 |
GO:0014056 | regulation of acetylcholine secretion | 1.534576e-3 |
GO:0060996 | dendritic spine development | 1.608320e-3 |
GO:0002036 | regulation of L-glutamate transport | 1.639507e-3 |
GO:0071157 | negative regulation of cell cycle arrest | 1.647504e-3 |
GO:0006513 | protein monoubiquitination | 1.656463e-3 |
GO:0009143 | nucleoside triphosphate catabolic process | 1.720602e-3 |
GO:0060620 | regulation of cholesterol import | 1.723794e-3 |
GO:0002523 | leukocyte migration involved in inflammatory response | 1.723794e-3 |
GO:0060340 | positive regulation of type I interferon-mediated signaling pathway | 1.723794e-3 |
GO:0032321 | positive regulation of Rho GTPase activity | 1.781982e-3 |
GO:0032922 | circadian regulation of gene expression | 1.855878e-3 |
GO:0007257 | activation of JUN kinase activity | 1.861738e-3 |
GO:0002679 | respiratory burst involved in defense response | 1.947787e-3 |
GO:0071636 | positive regulation of transforming growth factor beta production | 1.963877e-3 |
GO:0045647 | negative regulation of erythrocyte differentiation | 1.963877e-3 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 1.993829e-3 |
GO:0045922 | negative regulation of fatty acid metabolic process | 2.024703e-3 |
GO:0032367 | intracellular cholesterol transport | 2.072752e-3 |
GO:0032774 | RNA biosynthetic process | 2.121657e-3 |
GO:0006351 | transcription, DNA-dependent | 2.152722e-3 |
GO:0071394 | cellular response to testosterone stimulus | 2.164085e-3 |
GO:0001869 | negative regulation of complement activation, lectin pathway | 2.164085e-3 |
GO:0043153 | entrainment of circadian clock by photoperiod | 2.164085e-3 |
GO:0032966 | negative regulation of collagen biosynthetic process | 2.164085e-3 |
GO:0032915 | positive regulation of transforming growth factor beta2 production | 2.164085e-3 |
GO:0046038 | GMP catabolic process | 2.169080e-3 |
GO:0051725 | protein de-ADP-ribosylation | 2.169080e-3 |
GO:0050689 | negative regulation of defense response to virus by host | 2.169080e-3 |
GO:0032264 | IMP salvage | 2.169080e-3 |
GO:0032263 | GMP salvage | 2.169080e-3 |
GO:0006178 | guanine salvage | 2.169080e-3 |
GO:0006493 | protein O-linked glycosylation | 2.189858e-3 |
GO:0032049 | cardiolipin biosynthetic process | 2.239008e-3 |
GO:0002675 | positive regulation of acute inflammatory response | 2.324241e-3 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 2.334340e-3 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 2.347508e-3 |
GO:0006565 | L-serine catabolic process | 2.363832e-3 |
GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 2.416748e-3 |
GO:0034421 | post-translational protein acetylation | 2.416748e-3 |
GO:0097107 | postsynaptic density assembly | 2.416748e-3 |
GO:0035419 | activation of MAPK activity involved in innate immune response | 2.416748e-3 |
GO:0034436 | glycoprotein transport | 2.416748e-3 |
GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade | 2.432516e-3 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 2.492599e-3 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 2.492599e-3 |
GO:0051289 | protein homotetramerization | 2.514650e-3 |
GO:0046782 | regulation of viral transcription | 2.553772e-3 |
GO:0061032 | visceral serous pericardium development | 2.617178e-3 |
GO:0045073 | regulation of chemokine biosynthetic process | 2.617178e-3 |
GO:0007440 | foregut morphogenesis | 2.643055e-3 |
GO:0043921 | modulation by host of viral transcription | 2.656253e-3 |
GO:0043558 | regulation of translational initiation in response to stress | 2.684543e-3 |
GO:0033523 | histone H2B ubiquitination | 2.796951e-3 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 2.796951e-3 |
GO:0045654 | positive regulation of megakaryocyte differentiation | 2.883243e-3 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 2.883243e-3 |
GO:0032790 | ribosome disassembly | 2.896758e-3 |
GO:0019101 | female somatic sex determination | 2.896758e-3 |
GO:0042703 | menstruation | 2.896758e-3 |
GO:0042073 | intraflagellar transport | 2.896758e-3 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 2.896758e-3 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 2.896758e-3 |
GO:0018293 | protein-FAD linkage | 2.896758e-3 |
GO:0009259 | ribonucleotide metabolic process | 2.928307e-3 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 2.964143e-3 |
GO:0043249 | erythrocyte maturation | 3.056412e-3 |
GO:0009435 | NAD biosynthetic process | 3.199136e-3 |
GO:0090179 | planar cell polarity pathway involved in neural tube closure | 3.324442e-3 |
GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase | 3.422456e-3 |
GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation | 3.422456e-3 |
GO:0006413 | translational initiation | 3.446361e-3 |
GO:0046328 | regulation of JNK cascade | 3.457394e-3 |
GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 3.488730e-3 |
GO:0060711 | labyrinthine layer development | 3.529601e-3 |
GO:0002019 | regulation of renal output by angiotensin | 3.580822e-3 |
GO:0070316 | regulation of G0 to G1 transition | 3.580822e-3 |
GO:0030851 | granulocyte differentiation | 3.582243e-3 |
GO:0048143 | astrocyte activation | 3.613149e-3 |
GO:0007258 | JUN phosphorylation | 3.647631e-3 |
GO:0070171 | negative regulation of tooth mineralization | 3.685124e-3 |
GO:0032048 | cardiolipin metabolic process | 3.691409e-3 |
GO:0051823 | regulation of synapse structural plasticity | 3.707053e-3 |
GO:0002885 | positive regulation of hypersensitivity | 3.765318e-3 |
GO:0030100 | regulation of endocytosis | 3.794796e-3 |
GO:0060997 | dendritic spine morphogenesis | 3.840039e-3 |
GO:0046330 | positive regulation of JNK cascade | 3.917133e-3 |
GO:0044270 | cellular nitrogen compound catabolic process | 3.991712e-3 |
GO:0048850 | hypophysis morphogenesis | 3.998381e-3 |
GO:0046836 | glycolipid transport | 4.139195e-3 |
GO:0070781 | response to biotin | 4.155267e-3 |
GO:0033700 | phospholipid efflux | 4.244664e-3 |
GO:0009141 | nucleoside triphosphate metabolic process | 4.318509e-3 |
GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus | 4.353655e-3 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 4.361987e-3 |
GO:0046755 | non-lytic virus budding | 4.392564e-3 |
GO:0018364 | peptidyl-glutamine methylation | 4.392564e-3 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 4.411323e-3 |
GO:0006195 | purine nucleotide catabolic process | 4.515242e-3 |
GO:2000242 | negative regulation of reproductive process | 4.526125e-3 |
GO:0045780 | positive regulation of bone resorption | 4.530365e-3 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 4.556757e-3 |
GO:0060038 | cardiac muscle cell proliferation | 4.565803e-3 |
GO:0034105 | positive regulation of tissue remodeling | 4.569850e-3 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 4.570820e-3 |
GO:0003218 | cardiac left ventricle formation | 4.607502e-3 |
GO:0045606 | positive regulation of epidermal cell differentiation | 4.607502e-3 |
GO:0032728 | positive regulation of interferon-beta production | 4.615852e-3 |
GO:0070265 | necrotic cell death | 4.678418e-3 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 4.680105e-3 |
GO:0032648 | regulation of interferon-beta production | 4.731376e-3 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 4.791448e-3 |
GO:0002579 | positive regulation of antigen processing and presentation | 4.793828e-3 |
GO:0042053 | regulation of dopamine metabolic process | 4.850577e-3 |
GO:0030502 | negative regulation of bone mineralization | 4.854579e-3 |
GO:0031652 | positive regulation of heat generation | 4.871059e-3 |
GO:0030878 | thyroid gland development | 4.893525e-3 |
GO:2000273 | positive regulation of receptor activity | 4.926703e-3 |
GO:0043507 | positive regulation of JUN kinase activity | 4.969421e-3 |
GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 4.979729e-3 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 5.046921e-3 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 5.240869e-3 |
GO:0009648 | photoperiodism | 5.240869e-3 |
GO:0016048 | detection of temperature stimulus | 5.246359e-3 |
GO:0019430 | removal of superoxide radicals | 5.474570e-3 |
GO:0034655 | nucleobase-containing compound catabolic process | 5.486568e-3 |
GO:0014051 | gamma-aminobutyric acid secretion | 5.541120e-3 |
GO:0008306 | associative learning | 5.572285e-3 |
GO:0010623 | developmental programmed cell death | 5.586940e-3 |
GO:0050766 | positive regulation of phagocytosis | 5.587673e-3 |
GO:0009166 | nucleotide catabolic process | 5.613509e-3 |
GO:0060458 | right lung development | 5.670362e-3 |
GO:0043045 | DNA methylation involved in embryo development | 5.672717e-3 |
GO:0019285 | glycine betaine biosynthetic process from choline | 5.672717e-3 |
GO:0010897 | negative regulation of triglyceride catabolic process | 5.672717e-3 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 5.672717e-3 |
GO:0008542 | visual learning | 5.710545e-3 |
GO:0045839 | negative regulation of mitosis | 5.877602e-3 |
GO:0042069 | regulation of catecholamine metabolic process | 5.935851e-3 |
GO:0032874 | positive regulation of stress-activated MAPK cascade | 5.935851e-3 |
GO:0070168 | negative regulation of biomineral tissue development | 6.004347e-3 |
GO:2000657 | negative regulation of apolipoprotein binding | 6.014330e-3 |
GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process | 6.014330e-3 |
GO:2000781 | positive regulation of double-strand break repair | 6.014330e-3 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 6.014330e-3 |
GO:0019047 | provirus integration | 6.014330e-3 |
GO:0051984 | positive regulation of chromosome segregation | 6.211622e-3 |
GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway | 6.211622e-3 |
GO:0008617 | guanosine metabolic process | 6.211622e-3 |
GO:0007004 | telomere maintenance via telomerase | 6.211622e-3 |
GO:0045806 | negative regulation of endocytosis | 6.328237e-3 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 6.373317e-3 |
GO:2000195 | negative regulation of female gonad development | 6.378211e-3 |
GO:0046700 | heterocycle catabolic process | 6.426402e-3 |
GO:0072523 | purine-containing compound catabolic process | 6.478098e-3 |
GO:0050706 | regulation of interleukin-1 beta secretion | 6.480159e-3 |
GO:0006837 | serotonin transport | 6.493488e-3 |
GO:0046112 | nucleobase biosynthetic process | 6.554802e-3 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 6.600030e-3 |
GO:0048617 | embryonic foregut morphogenesis | 6.670904e-3 |
GO:0051900 | regulation of mitochondrial depolarization | 6.687607e-3 |
GO:0001975 | response to amphetamine | 6.693020e-3 |
GO:0014037 | Schwann cell differentiation | 6.780744e-3 |
GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus | 6.840345e-3 |
GO:0048247 | lymphocyte chemotaxis | 6.934050e-3 |
GO:0070170 | regulation of tooth mineralization | 6.970034e-3 |
GO:0030223 | neutrophil differentiation | 6.970034e-3 |
GO:0002678 | positive regulation of chronic inflammatory response | 6.970034e-3 |
GO:0070318 | positive regulation of G0 to G1 transition | 6.987511e-3 |
GO:2000286 | receptor internalization involved in canonical Wnt receptor signaling pathway | 6.987511e-3 |
GO:0060658 | nipple morphogenesis | 6.987511e-3 |
GO:0019254 | carnitine metabolic process, CoA-linked | 6.987511e-3 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 6.987511e-3 |
GO:0006656 | phosphatidylcholine biosynthetic process | 7.112969e-3 |
GO:0017156 | calcium ion-dependent exocytosis | 7.159114e-3 |
GO:0032226 | positive regulation of synaptic transmission, dopaminergic | 7.174837e-3 |
GO:0072093 | metanephric renal vesicle formation | 7.375904e-3 |
GO:0002268 | follicular dendritic cell differentiation | 7.375904e-3 |
GO:0002741 | positive regulation of cytokine secretion involved in immune response | 7.375904e-3 |
GO:0006760 | folic acid-containing compound metabolic process | 7.436338e-3 |
GO:0009452 | RNA capping | 7.480110e-3 |
GO:0060621 | negative regulation of cholesterol import | 7.480110e-3 |
GO:0030823 | regulation of cGMP metabolic process | 7.584881e-3 |
GO:0048339 | paraxial mesoderm development | 7.652964e-3 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 7.654775e-3 |
GO:0030300 | regulation of intestinal cholesterol absorption | 7.838418e-3 |
GO:0060461 | right lung morphogenesis | 7.904160e-3 |
GO:0090131 | mesenchyme migration | 7.904160e-3 |
GO:0060446 | branching involved in open tracheal system development | 7.904160e-3 |
GO:0014822 | detection of wounding | 7.904160e-3 |
GO:0048613 | embryonic ectodermal digestive tract morphogenesis | 7.904160e-3 |
GO:0002380 | immunoglobulin secretion involved in immune response | 7.904160e-3 |
GO:0048371 | lateral mesodermal cell differentiation | 7.904160e-3 |
GO:0031129 | inductive cell-cell signaling | 7.908813e-3 |
GO:0060376 | positive regulation of mast cell differentiation | 7.908813e-3 |
GO:0050823 | peptide antigen stabilization | 7.908813e-3 |
GO:0007023 | post-chaperonin tubulin folding pathway | 7.908813e-3 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 7.908813e-3 |
GO:0000238 | zygotene | 7.908813e-3 |
GO:0032375 | negative regulation of cholesterol transport | 8.014245e-3 |
GO:2000143 | negative regulation of transcription initiation, DNA-dependent | 8.071550e-3 |
GO:0042744 | hydrogen peroxide catabolic process | 8.240266e-3 |
GO:0046322 | negative regulation of fatty acid oxidation | 8.347130e-3 |
GO:0000052 | citrulline metabolic process | 8.411884e-3 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 8.454973e-3 |
GO:0070836 | caveola assembly | 8.552449e-3 |
GO:0034214 | protein hexamerization | 8.629558e-3 |
GO:0031584 | activation of phospholipase D activity | 8.629558e-3 |
GO:0007264 | small GTPase mediated signal transduction | 8.630637e-3 |
GO:0034382 | chylomicron remnant clearance | 8.632887e-3 |
GO:0032769 | negative regulation of monooxygenase activity | 8.636593e-3 |
GO:0043313 | regulation of neutrophil degranulation | 8.775131e-3 |
GO:0060419 | heart growth | 8.855386e-3 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 8.855386e-3 |
GO:0002318 | myeloid progenitor cell differentiation | 9.029324e-3 |
GO:0030825 | positive regulation of cGMP metabolic process | 9.210075e-3 |
GO:0090083 | regulation of inclusion body assembly | 9.234970e-3 |
GO:0051151 | negative regulation of smooth muscle cell differentiation | 9.354467e-3 |
GO:0070375 | BMK cascade | 9.354467e-3 |
GO:0048148 | behavioral response to cocaine | 9.479368e-3 |
GO:0033169 | histone H3-K9 demethylation | 9.527960e-3 |
GO:0032506 | cytokinetic process | 9.527960e-3 |
GO:0002863 | positive regulation of inflammatory response to antigenic stimulus | 9.530168e-3 |
GO:0015812 | gamma-aminobutyric acid transport | 9.721468e-3 |
GO:0002827 | positive regulation of T-helper 1 type immune response | 1.010992e-2 |
GO:0001678 | cellular glucose homeostasis | 1.016343e-2 |
GO:0060627 | regulation of vesicle-mediated transport | 1.026685e-2 |
GO:0006412 | translation | 1.027832e-2 |
GO:0000189 | MAPK import into nucleus | 1.035296e-2 |
GO:0043088 | regulation of Cdc42 GTPase activity | 1.035910e-2 |
GO:0034261 | negative regulation of Ras GTPase activity | 1.057220e-2 |
GO:0034645 | cellular macromolecule biosynthetic process | 1.061578e-2 |
GO:0061034 | olfactory bulb mitral cell layer development | 1.067841e-2 |
GO:0033025 | regulation of mast cell apoptosis | 1.067841e-2 |
GO:0019369 | arachidonic acid metabolic process | 1.075841e-2 |
GO:0007095 | mitotic cell cycle G2/M transition DNA damage checkpoint | 1.081987e-2 |
GO:0003229 | ventricular cardiac muscle tissue development | 1.089368e-2 |
GO:0000578 | embryonic axis specification | 1.093822e-2 |
GO:0016045 | detection of bacterium | 1.106148e-2 |
GO:0050994 | regulation of lipid catabolic process | 1.108704e-2 |
GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 1.108901e-2 |
GO:0061084 | negative regulation of protein refolding | 1.108901e-2 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 1.108901e-2 |
GO:0001300 | chronological cell aging | 1.108901e-2 |
GO:0000414 | regulation of histone H3-K36 methylation | 1.108901e-2 |
GO:0006407 | rRNA export from nucleus | 1.108901e-2 |
GO:0045684 | positive regulation of epidermis development | 1.110342e-2 |
GO:0001675 | acrosome assembly | 1.137215e-2 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 1.137215e-2 |
GO:0071542 | dopaminergic neuron differentiation | 1.141067e-2 |
GO:0002724 | regulation of T cell cytokine production | 1.144460e-2 |
GO:0060911 | cardiac cell fate commitment | 1.154887e-2 |
GO:0090224 | regulation of spindle organization | 1.168482e-2 |
GO:0007352 | zygotic specification of dorsal/ventral axis | 1.188589e-2 |
GO:0071479 | cellular response to ionizing radiation | 1.199901e-2 |
GO:2000194 | regulation of female gonad development | 1.203387e-2 |
GO:0046874 | quinolinate metabolic process | 1.206556e-2 |
GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation | 1.206556e-2 |
GO:0022409 | positive regulation of cell-cell adhesion | 1.220135e-2 |
GO:0032743 | positive regulation of interleukin-2 production | 1.222404e-2 |
GO:0032467 | positive regulation of cytokinesis | 1.222404e-2 |
GO:0031914 | negative regulation of synaptic plasticity | 1.229583e-2 |
GO:0045796 | negative regulation of intestinal cholesterol absorption | 1.229583e-2 |
GO:0070278 | extracellular matrix constituent secretion | 1.229583e-2 |
GO:0010949 | negative regulation of intestinal phytosterol absorption | 1.229583e-2 |
GO:0010260 | organ senescence | 1.229583e-2 |
GO:0002693 | positive regulation of cellular extravasation | 1.229583e-2 |
GO:0014895 | smooth muscle hypertrophy | 1.248701e-2 |
GO:0010701 | positive regulation of norepinephrine secretion | 1.248701e-2 |
GO:0003106 | negative regulation of glomerular filtration by angiotensin | 1.248701e-2 |
GO:0051171 | regulation of nitrogen compound metabolic process | 1.271541e-2 |
GO:0007141 | male meiosis I | 1.272207e-2 |
GO:2000484 | positive regulation of interleukin-8 secretion | 1.281227e-2 |
GO:0002074 | extraocular skeletal muscle development | 1.298651e-2 |
GO:0051835 | positive regulation of synapse structural plasticity | 1.298651e-2 |
GO:0072166 | posterior mesonephric tubule development | 1.298651e-2 |
GO:0035802 | adrenal cortex formation | 1.298651e-2 |
GO:0072521 | purine-containing compound metabolic process | 1.311520e-2 |
GO:0010831 | positive regulation of myotube differentiation | 1.341246e-2 |
GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway | 1.356346e-2 |
GO:0050764 | regulation of phagocytosis | 1.360914e-2 |
GO:0032715 | negative regulation of interleukin-6 production | 1.374111e-2 |
GO:0032929 | negative regulation of superoxide anion generation | 1.376029e-2 |
GO:0021965 | spinal cord ventral commissure morphogenesis | 1.376029e-2 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 1.379112e-2 |
GO:0043103 | hypoxanthine salvage | 1.379112e-2 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 1.379112e-2 |
GO:0045994 | positive regulation of translational initiation by iron | 1.379112e-2 |
GO:0032261 | purine nucleotide salvage | 1.379112e-2 |
GO:0021508 | floor plate formation | 1.379112e-2 |
GO:0002037 | negative regulation of L-glutamate transport | 1.379112e-2 |
GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.379112e-2 |
GO:0006168 | adenine salvage | 1.379112e-2 |
GO:0003323 | type B pancreatic cell development | 1.386531e-2 |
GO:0090273 | regulation of somatostatin secretion | 1.403627e-2 |
GO:0032148 | activation of protein kinase B activity | 1.403627e-2 |
GO:0070079 | histone H4-R3 demethylation | 1.408620e-2 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 1.408620e-2 |
GO:0070078 | histone H3-R2 demethylation | 1.408620e-2 |
GO:0033630 | positive regulation of cell adhesion mediated by integrin | 1.413784e-2 |
GO:0006163 | purine nucleotide metabolic process | 1.454261e-2 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 1.469232e-2 |
GO:0061153 | trachea gland development | 1.480970e-2 |
GO:0032606 | type I interferon production | 1.480970e-2 |
GO:0032007 | negative regulation of TOR signaling cascade | 1.480970e-2 |
GO:0006577 | betaine metabolic process | 1.481380e-2 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 1.490931e-2 |
GO:0071881 | inhibition of adenylate cyclase activity by adrenergic receptor signaling pathway | 1.490931e-2 |
GO:0071882 | activation of phospholipase C activity by adrenergic receptor signaling pathway | 1.490931e-2 |
GO:0014057 | positive regulation of acetylcholine secretion | 1.490931e-2 |
GO:0046483 | heterocycle metabolic process | 1.492503e-2 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 1.509448e-2 |
GO:0072284 | metanephric S-shaped body morphogenesis | 1.513461e-2 |
GO:0006467 | protein thiol-disulfide exchange | 1.513461e-2 |
GO:0072278 | metanephric comma-shaped body morphogenesis | 1.513461e-2 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 1.523446e-2 |
GO:0060375 | regulation of mast cell differentiation | 1.530698e-2 |
GO:0030730 | sequestering of triglyceride | 1.530698e-2 |
GO:0031326 | regulation of cellular biosynthetic process | 1.572508e-2 |
GO:0019363 | pyridine nucleotide biosynthetic process | 1.575457e-2 |
GO:0032928 | regulation of superoxide anion generation | 1.575484e-2 |
GO:0030308 | negative regulation of cell growth | 1.597976e-2 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 1.599871e-2 |
GO:0002275 | myeloid cell activation involved in immune response | 1.601380e-2 |
GO:0043173 | nucleotide salvage | 1.651673e-2 |
GO:0007228 | positive regulation of hh target transcription factor activity | 1.651673e-2 |
GO:2000779 | regulation of double-strand break repair | 1.664783e-2 |
GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production | 1.704067e-2 |
GO:0051454 | intracellular pH elevation | 1.704067e-2 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 1.704067e-2 |
GO:0090102 | cochlea development | 1.705928e-2 |
GO:0051781 | positive regulation of cell division | 1.718934e-2 |
GO:0030539 | male genitalia development | 1.735474e-2 |
GO:0033484 | nitric oxide homeostasis | 1.738333e-2 |
GO:0035928 | rRNA import into mitochondrion | 1.738333e-2 |
GO:0006598 | polyamine catabolic process | 1.738333e-2 |
GO:0071895 | odontoblast differentiation | 1.738931e-2 |
GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 1.740001e-2 |
GO:0042220 | response to cocaine | 1.804783e-2 |
GO:0043691 | reverse cholesterol transport | 1.817229e-2 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.846086e-2 |
GO:0001820 | serotonin secretion | 1.853410e-2 |
GO:0072109 | glomerular mesangium development | 1.857762e-2 |
GO:0060712 | spongiotrophoblast layer development | 1.857762e-2 |
GO:0032872 | regulation of stress-activated MAPK cascade | 1.870669e-2 |
GO:0060561 | apoptosis involved in morphogenesis | 1.870669e-2 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 1.870669e-2 |
GO:0032374 | regulation of cholesterol transport | 1.874123e-2 |
GO:0045682 | regulation of epidermis development | 1.892409e-2 |
GO:0043330 | response to exogenous dsRNA | 1.906356e-2 |
GO:0033483 | gas homeostasis | 1.920521e-2 |
GO:0031650 | regulation of heat generation | 1.927477e-2 |
GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain | 1.931895e-2 |
GO:0090084 | negative regulation of inclusion body assembly | 1.931895e-2 |
GO:0007418 | ventral midline development | 1.931895e-2 |
GO:0061349 | planar cell polarity pathway involved in cardiac right atrium morphogenesis | 1.951458e-2 |
GO:0061350 | planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 1.951458e-2 |
GO:0061354 | planar cell polarity pathway involved in pericardium morphogenesis | 1.951458e-2 |
GO:0061348 | planar cell polarity pathway involved in ventricular septum morphogenesis | 1.951458e-2 |
GO:0072092 | ureteric bud invasion | 1.951458e-2 |
GO:0061347 | planar cell polarity pathway involved in outflow tract morphogenesis | 1.951458e-2 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 1.951458e-2 |
GO:0042501 | serine phosphorylation of STAT protein | 1.951458e-2 |
GO:0060210 | metestrus | 1.951458e-2 |
GO:0048680 | positive regulation of axon regeneration | 1.967395e-2 |
GO:0006659 | phosphatidylserine biosynthetic process | 1.967395e-2 |
GO:0006355 | regulation of transcription, DNA-dependent | 1.969799e-2 |
GO:0051225 | spindle assembly | 1.971893e-2 |
GO:0060124 | positive regulation of growth hormone secretion | 2.054120e-2 |
GO:0008615 | pyridoxine biosynthetic process | 2.080173e-2 |
GO:0046580 | negative regulation of Ras protein signal transduction | 2.100065e-2 |
GO:0065001 | specification of axis polarity | 2.104979e-2 |
GO:0033505 | floor plate morphogenesis | 2.104979e-2 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 2.106978e-2 |
GO:0045124 | regulation of bone resorption | 2.111671e-2 |
GO:0035725 | sodium ion transmembrane transport | 2.115955e-2 |
GO:0015914 | phospholipid transport | 2.118290e-2 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 2.155509e-2 |
GO:0044091 | membrane biogenesis | 2.171392e-2 |
GO:0007527 | adult somatic muscle development | 2.171392e-2 |
GO:0060751 | branch elongation involved in mammary gland duct branching | 2.187974e-2 |
GO:0033603 | positive regulation of dopamine secretion | 2.194872e-2 |
GO:0042758 | long-chain fatty acid catabolic process | 2.194872e-2 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 2.194872e-2 |
GO:0042413 | carnitine catabolic process | 2.194872e-2 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 2.194872e-2 |
GO:0006420 | arginyl-tRNA aminoacylation | 2.194872e-2 |
GO:0007089 | traversing start control point of mitotic cell cycle | 2.194872e-2 |
GO:0071333 | cellular response to glucose stimulus | 2.204859e-2 |
GO:0051013 | microtubule severing | 2.213612e-2 |
GO:0001732 | formation of translation initiation complex | 2.213612e-2 |
GO:0032119 | sequestering of zinc ion | 2.213612e-2 |
GO:0070995 | NADPH oxidation | 2.227981e-2 |
GO:2000406 | positive regulation of T cell migration | 2.228607e-2 |
GO:0010468 | regulation of gene expression | 2.249710e-2 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 2.257690e-2 |